KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Xenon Pharmaceuticals (XENE) Interest & Investment Income (2016 - 2025)

Historic Interest & Investment Income for Xenon Pharmaceuticals (XENE) over the last 13 years, with Q3 2025 value amounting to $6.2 million.

  • Xenon Pharmaceuticals' Interest & Investment Income fell 3991.67% to $6.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $30.9 million, marking a year-over-year decrease of 2499.76%. This contributed to the annual value of $41.9 million for FY2024, which is 5185.73% up from last year.
  • Latest data reveals that Xenon Pharmaceuticals reported Interest & Investment Income of $6.2 million as of Q3 2025, which was down 3991.67% from $7.2 million recorded in Q2 2025.
  • Over the past 5 years, Xenon Pharmaceuticals' Interest & Investment Income peaked at $11.4 million during Q1 2024, and registered a low of $57000.0 during Q3 2021.
  • In the last 5 years, Xenon Pharmaceuticals' Interest & Investment Income had a median value of $6.2 million in 2025 and averaged $5.3 million.
  • Its Interest & Investment Income has fluctuated over the past 5 years, first plummeted by 9210.53% in 2021, then skyrocketed by 527894.74% in 2022.
  • Quarter analysis of 5 years shows Xenon Pharmaceuticals' Interest & Investment Income stood at $191000.0 in 2021, then skyrocketed by 2236.65% to $4.5 million in 2022, then skyrocketed by 94.73% to $8.7 million in 2023, then rose by 8.41% to $9.4 million in 2024, then crashed by 34.13% to $6.2 million in 2025.
  • Its Interest & Investment Income was $6.2 million in Q3 2025, compared to $7.2 million in Q2 2025 and $8.1 million in Q1 2025.